Betazole: Difference between revisions
No edit summary |
m Protected "Betazole": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 3: | Line 3: | ||
| Verifiedfields = changed | | Verifiedfields = changed | ||
| verifiedrevid = 459977851 | | verifiedrevid = 459977851 | ||
| ImageFile = betazole | | ImageFile = betazole.png | ||
| ImageSize = 180px | | ImageSize = 180px | ||
| IUPACName = 2-(2''H''-Pyrazol-3-yl)ethanamine | | IUPACName = 2-(2''H''-Pyrazol-3-yl)ethanamine | ||
| Line 55: | Line 55: | ||
}} | }} | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Betazole''' is a histamine [[histamine H2 receptor|H<sub>2</sub> receptor]] [[agonist]]. Also known as Ametazole. Betazole hydrochloride is known as gastramine and histalog. | '''Betazole''' is a histamine [[histamine H2 receptor|H<sub>2</sub> receptor]] [[agonist]]. Also known as Ametazole. Betazole hydrochloride is known as gastramine and histalog. | ||
| Line 66: | Line 70: | ||
==References== | ==References== | ||
{{Reflist|2}} | |||
{{Diagnostic agents}} | {{Diagnostic agents}} | ||
[[Category: | [[Category:Drug]] | ||
[[Category:Ethylamines]] | [[Category:Ethylamines]] | ||
Latest revision as of 18:06, 18 August 2015
| |
| Names | |
|---|---|
| IUPAC name
2-(2H-Pyrazol-3-yl)ethanamine
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
PubChem CID
|
|
| UNII | |
| |
| |
| Properties | |
| C5H9N3 | |
| Molar mass | 111.145 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
 verify (what is  ?)
| |
| Infobox references | |
|
WikiDoc Resources for Betazole |
|
Articles |
|---|
|
Most recent articles on Betazole |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Betazole at Clinical Trials.gov Clinical Trials on Betazole at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Betazole
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating Betazole Risk calculators and risk factors for Betazole
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Betazole |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Betazole is a histamine H2 receptor agonist. Also known as Ametazole. Betazole hydrochloride is known as gastramine and histalog.
It has been used as a gastric stimulant to test for maximal production of gastric secretion activity [1] The test can be used in diagnosis of diseases such as Zollinger-Ellison syndrome where there is excess acid production, in this case driven by over production of gastrin. The volume of acid secretion is measured following administration of betazole, diagnosis being secretion greater than 60% of the maximal acid secretion following betazole stimulation. This procedure can lead to complications and should be avoided in subjects with coronary artery disease [2] It is also used in diagnosis of gastritis in association with a test for secretin activity
Betazole is used as a stimulant in preference to histamine because of its specificity for the H2 receptor and its advantage of not generating the undesirable side effects that histamine would induce. It therefore does not require concomitant use of antihistaminic compounds to block the actions of histamine at other histamine receptor types.
Its action in stimulating histamine release can be of use when testing the effectiveness of H2 receptor blocking drugs such as Nizatidine.[3]
References
- ↑ Wruble LD Cummins AJ Goldenberg J Schapiro H (1967). "The effect of intravenous histalog on gastric secretion in man". Digestive Diseases and Sciences. 12 (11): 1087–1090. doi:10.1007/BF02233873. PMID 6057052.
- ↑ Stoller JL Holubitsky IB Harrison RC Munro AI (1970). "Complications of the histalog test of gastric acid secretion". Digestive Diseases and Sciences. 15 (7): 647–651. doi:10.1007/BF02236024. PMID 4951403.
- ↑ Hammond JB, Offen WW (1988). "Effect of nizatidine and cimetidine on betazole-stimulated gastric secretion of normal subjects: comparison of effects on acid, water, and pepsin". Am J Gastroenterol. 83 (1): 32–6. PMID 2892392.